ラング、ベンジャミンLang, Benjamin O. (ベン)

オブカウンセル

東京 + 81.3.6744.1605

ベン・ラングは、国内外のクライアントのクロスボーダー取引に関して、豊富なアドバイス経験を有しています。東京およびニューヨークにおける約15年間の実務経験の中で、上場・非上場企業のM&A、企業分割、スピンアウト、ジョイント・ベンチャー、その他の投資などを含めて、多岐にわたる戦略的取引および商取引についてアドバイスを行っています。また、特にライフサイエンス業界に注力し、国際的な共同開発、ライセンス、販売代理、その他の取極めを扱い、また、日本での市場参入および臨床試験について、海外のクライアントにアドバイスを提供しています。さらに、日本の金融機関やエネルギー産業についても豊かな経験を有しています。

2017年のジョーンズ・デイ入所以前の経験として、米国大手小売店の日本撤退、米国再生可能エネルギー企業の複数の日本プロジェクトからの撤退、国内上場企業による米国医療機器メーカーの買収、米国通信事業会社による日本企業との合弁事業設立などがあります。

ベンは京都近郊のポリマーの研究所でのインターシップや北海道の市役所での勤務経験など含め、30年以上も日本と深いかかわりがあります。日本語、英語による業務が可能です。

担当案件

  • Otsuka acquires new, high-sensitivity biomarker measurement technology from Konica MinoltaJones Day advised Otsuka Pharmaceutical Co., Ltd. in the acquisition of Konica Minolta's new high-sensitivity biomarker measurement technology that uses SPFS (surface plasmon field-enhanced fluorescence spectroscopy) technology.
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • EagleTree Capital acquires IntegreonJones Day advised EagleTree Capital in connection with the acquisition and financing of Integreon, a leading global managed services provider, from NewQuest Capital Partners.
  • ETS acquires TOEFL® assets of Council on International Educational Exchange (CIEE)-JapanJones Day advised ETS in the acquisition of the TOEFL® assets of the Council on International Educational Exchange (CIEE)-Japan.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Sumitovant Biopharma acquires remaining stake in Urovant SciencesJones Day advised Sumitovant Biopharma in its acquisition of all of the outstanding shares of Urovant Sciences Ltd. not already owned by Sumitovant at a price of $16.25 per share in cash.
  • Furukawa Electric and Superior Essex global joint venture finalizedJones Day advised Furukawa Electric Co., Ltd. in its finalization of a global joint venture with Superior Essex Inc.
  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • Torii Pharmaceutical acquires exclusive marketing and licensing rights from BioCryst for BCX7353 in JapanJones Day represented Torii Pharmaceutical Co., Ltd. in drafting, reviewing, and negotiating its commercialization and license agreement with BioCryst Pharmaceuticals, Inc.
  • Kaga Electronics acquires Fujitsu Electronics Inc.Jones Day advised Kaga Electronics Co., Ltd. in its acquisition of Fujitsu Electronics Inc.
  • Hudson's Bay Company sells Gilt Groupe K.K. to Gladd Inc.Jones Day advised Hudson's Bay Company in the sale of its subsidiary, Gilt Groupe K.K., to Gladd Inc.
  • MassMutual International sells 85.1 percent of MassMutual Japan to Nippon LifeJones Day advised MassMutual International LLC in its sale of 85.1 percent of the shares of MassMutual Japan, MassMutual's wholly-owned life insurance and wealth affiliate, to Nippon Life for JPY104.2 billion (approximately US$955 million).
  • PAG invests in Key Safety Systems to finance acquisition of global assets of Takata CorporationJones Day represented PAG Asia Capital Ltd. and PAG Asia II LP in connection with its investment in Key Safety Systems, a subsidiary of China-based Ningbo Joyson Electronic Corporation, to finance the acquisition of substantially all of the global assets of Takata Corporation out of bankruptcy in the U.S. and Japan and certain non-bankruptcy transactions elsewhere in the world.
  • PAG Holdings sells minority interest to Blackstone Strategic Capital Holdings FundJones Day represented PAG Holdings Ltd., one of Asia’s largest independent alternative asset managers, in connection with its sale of a minority interest in PAG to the Blackstone Strategic Capital Holdings Fund.
  • 講演

    • November 2021
      医薬品企業法務研究会:英文契約におけるボイラープレート条項
    • October 2020
      医薬品企業法務研究会:英文供給契約/コモンローの視点から見た不可抗力条項